This study revealed that the switch from PKM1 to PKM2 occurs in lymphoma cells prior to T-ALL, indicating that PKM2 activation is required but not sufficient for T-ALL progression in this mouse model. Here, PKM is linked to acute lymphoblastic leukemia.